Sensus Healthcare, Inc. Announces Pricing of Public Offering of Common Stock
BOCA RATON, Fla., Sept. 13, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has priced an underwritten public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share. Sensus has granted a 30-day option to purchase up to an additional […]
Sensus Healthcare, Inc. Announces Pricing of Public Offering of Common Stock
BOCA RATON, Fla., Sept. 13, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has priced an underwritten public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share. Sensus has granted a 30-day option to purchase up to an additional […]
Sensus Healthcare, Inc. Announces Commencement of Public Offering of Common Stock
BOCA RATON, Fla., Sept. 12, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it commenced a public offering of its common stock, par value $0.01 per share. B. Riley FBR is serving as the lead underwriter and sole book-running manager for the offering. Sensus intends to use the net proceeds from the offering […]
Sensus Healthcare, Inc. Announces Commencement of Public Offering of Common Stock
BOCA RATON, Fla., Sept. 12, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it commenced a public offering of its common stock, par value $0.01 per share. B. Riley FBR is serving as the lead underwriter and sole book-running manager for the offering. Sensus intends to use the net proceeds from the offering […]
Sensus Healthcare, Inc. Announces Commencement of Public Offering of Common Stock
BOCA RATON, Fla., Sept. 12, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it commenced a public offering of its common stock, par value $0.01 per share. B. Riley FBR is serving as the lead underwriter and sole book-running manager for the offering. Sensus intends to use the net proceeds from the offering […]
Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting
BOCA RATON, Fla., Sept. 7, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, participated at the National Cancer Care Alliance (NCCA) Leadership Board and Practice Quarterly […]
Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting
BOCA RATON, Fla., Sept. 7, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, participated at the National Cancer Care Alliance (NCCA) Leadership Board and Practice Quarterly […]
Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting
BOCA RATON, Fla., Sept. 7, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, participated at the National Cancer Care Alliance (NCCA) Leadership Board and Practice Quarterly […]
